Latest Precigen News & Updates

See the latest news and media coverage for Precigen. We track all announcements, press releases, and industry mentions in real time, all in one place.

Precigen

Commercial-stage biopharmaceutical company focused on precision medicines

precigen.com

Headquarters: Germantown, United States
Founded year: 2020
Company type: Public company
Number of employees: 150–200
Industry: Pharmaceuticals

Last updated Today

Latest news about Precigen

In short: Precigen achieved its first quarterly profit in Q2 2026 as sales of its FDA-approved RRP therapy, PAPZIMEOS, more than doubled.

Company announcements

August 4 Precigen

Precigen reports Q2 2026 financial results amid PAPZIMEOS growth

PAPZIMEOS revenue more than doubled to $53.1M, driving net income of $20.1M and the company's first quarterly profitability.

July 21 Precigen

Precigen to report Q2 2026 financial results and updates

The company will host a conference call on August 4, 2026 at 4:30 PM ET to discuss.

May 30 Precigen

Precigen presents new long-term durability data for PAPZIMEOS

83% of complete responders maintained response for at least 36 months, with five beyond four years, and the drug received seven-year market exclusivity.

May 27 Precigen

Precigen will present pivotal trial data at symposium

The data shows complete responses and reduced surgical debulking in recurrent respiratory papillomatosis patients.

Media coverage

September 10 Yahoo Finance

Can Papzimeos Drive Precigen's Growth Through the Rest of 2026?

Papzimeos is fueling Precigen's growth, with sales more than doubling sequentially in Q2 and demand continuing to rise in 2026.

August 25 FinanzNachrichten.de

Precigen, Inc.: Precigen's Strong Second Quarter Signals Significant Growth, Validates AdenoVerse Platform; PRGN-2009 Advances in HPV-Driven Cancers

The LongviewThe Company's New Drug, the First FDA-Approved Therapy for Recurrent Respiratory Papillomatosis (RRP), is Delivering Strong Commercial Traction While Highlighting the Broader...

August 20 Yahoo Finance

Reasons Why Investors Should Consider Betting on PGEN Stock

Precigen's Papzimeos drives rapid revenue growth, while market exclusivity, global expansion and its...

August 4 Investing.com

Precigen exceeds Q2 2026 forecasts thanks to the surge in PAPZIMEOS sales

In the longer term, management indicated that PAPZIMEOS has blockbuster potential in the US PRR market, which it estimates at...

Never miss news about Precigen

Track Precigen and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Precigen competitors & trending companies

Browse news for competitors to Precigen and other trending companies.